CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Efficacy and Safety of Oxaliplatin, 5-Fluorouracil, and Folinic Acid Combination Chemotherapy as First-Line Treatment in Metastatic or Recurrent Gastric Cancer

Han Jo Kim, Jun Young Eun, Young Woo Jeon, Jina Yun, Kyoung Ha Kim, Se Hyung Kim, Hyun Jung Kim, Sang-Cheol Lee, Sang Byung Bae, Chan Kyu Kim, Nam Su Lee, Kyu Taek Lee, Seong-Kyu Park, Jong-Ho Won, Dae Sik Hong, Hee Sook Park

Cancer Research and Treatment. 2011;43(3):154-159. Published online 2011 September 30 DOI: https://doi.org/10.4143/crt.2011.43.3.154

601 ORAL Infusional 5-fluorouracil/folinic acid plus oxaliplatin (FUFOX) versus capecitabine plus oxaliplatin (CAPOX) as first line treatment of metastatic colorectal carcinoma (MCRC): results of the safety and efficacy analysis

European Journal of Cancer Supplements. 2005;3(2):168

Link1 Link2

Efficacy and Safety of Oxaliplatin, 5-Fluorouracil, and Folinic Acid Combination Chemotherapy as First-Line Treatment in Metastatic or Recurrent Gastric Cancer

Cancer Research and Treatment. 2011;43(3):154-159

Link1

Link2

Oxaliplatin, 5-FU, Folinic Acid as First-line Palliative Chemotherapy in Elderly Patients with Metastatic or Recurrent Gastric Cancer

In Sil Choi, Do-Youn Oh, Byoung-Su Kim, Keun-Wook Lee, Jee Hyun Kim, Jong-Seok Lee

Cancer Research and Treatment. 2007;39(3):99

Link1

Link2

Sequential chemotherapy with dose-dense docetaxel, cisplatin, folinic acid and 5-fluorouracil (TCF-dd) followed by combination of oxaliplatin, folinic acid, 5-fluorouracil and irinotecan (COFFI) in metastatic gastric cancer: results of a phase II trial

Matteo Dalla Chiesa, Gianluca Tomasello, Sebastiano Buti, Rodrigo Kraft Rovere, Matteo Brighenti, Silvia Lazzarelli, Gianvito Donati, Rodolfo Passalacqua

Cancer Chemotherapy and Pharmacology. 2010;67(1):41-48

Link1

Link2 Link3

Comparison of Cisplatin-5-Fluorouracil-Folinic Acid versus Modified Docetaxel-Cisplatin-5-Fluorouracil Regimens in the First-Line Treatment of Metastatic Gastric Cancer

F. Tugba Kos, Dogan Uncu, Nuriye Özdemir, Burcin Budakoglu, Hatice Odabaş, Hüseyin Abali, Berna Oksuzoglu, Sercan Aksoy, Nurullah Zengin

Chemotherapy. 2011;57(3):230-235

Link1 Link2 Link3

A Pilot Study of Oxaliplatin, Fluorouracil and Folinic Acid (FOLFOX-6) as First-Line Chemotherapy in Advanced or Recurrent Gastric Cancer

Hui-Yan Luo, Rui-Hua Xu, Li Zhang, Yu-Hong Li, Yan-Xia Shi, Tong-Yu Lin, Bing Han, Feng Wang, Miao-Zhen Qiu, You-Jian He, Zhong-Zhen Guan

Chemotherapy. 2008;54(3):228-235

Link1 Link2

664 PUBLICATION Cetuximab in combination with irinotecan/5-fluorouracil (5-FU)/folinic acid (FA) (FOLFIRI) in the first-line treatment of metastatic colorectal cancer (mCRC)

European Journal of Cancer Supplements. 2005;3(2):188

Link1 Link2

Clinical and economic benefits of irinotecan in combination with 5-fluorouracil and folinic acid as first line treatment of metastatic colorectal cancer

D Cunningham, S Falk, D Jackson

British Journal of Cancer. 2002;86(11):1677-1683

Link1 Link2

Link3

Safety and efficacy of second-line treatment with folinic acid, 5-fluorouracil and irinotecan (FOLFIRI) in combination of panitumumab and bevacizumab for patients with metastatic colorectal cancer

Song Xie, Guoping Han, Zhikun Fan, Lifeng He, Wenbing Xu, Zhen Qin

Medical Oncology. 2014;31(7):

Link1

Link2 Link3

Safety and efficacy of weekly 5-fluorouracil/ folinic acid/oxaliplatin/irinotecan in the first-line treatment of gastrointestinal cancer

Stefan Peinert, Wilfried Grothe, Alexander Stein, Lutz P. Müller, Joern Ruessel, Wieland Voigt, Hans-Joachim Schmoll, Dirk Arnold

Therapeutic Advances in Medical Oncology. 2010;2(3):161-174

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.